Using mouse models, the study focused on why asparaginase—a natural enzyme used as a drug to treat the blood cancer—doesn’t always work.

Imbruvica plus Gazyva is the first chemotherapy-free regimen for chronic lymphocytic leukemia.

The professional wrestler has lived with the cancer since age 22.

Timothy Brown may have company after a man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.

Imbruvica plus Gazyva is the first chemotherapy-free regimen for chronic lymphocytic leukemia.

Venclexta alone or in combination with Rituxan improved progression-free survival in patients with chronic lymphocytic leukemia.

Researchers believe their greater understanding of leukemia stem cells will lead to more treatment options for people with the blood cancer.

A look back at some of the major news stories we covered this year.